These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 3147795

  • 1. Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts.
    Sarno EN, Espinosa M, Sampaio EP, Vieira LM, Figueiredo AA, Miranda CF, Esquenazi D, Salgado JL, Nogueira N.
    Braz J Med Biol Res; 1988; 21(3):461-70. PubMed ID: 3147795
    [Abstract] [Full Text] [Related]

  • 2. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
    Launois P, Huygen K, De Bruyn J, N'Diaye M, Diouf B, Sarthouj L, Grimaud J, Millan J.
    Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
    [Abstract] [Full Text] [Related]

  • 3. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
    Lima MC, Pereira GM, Rumjanek FD, Gomes HM, Duppre N, Sampaio EP, Alvim IM, Nery JA, Sarno EN, Pessolani MC.
    Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
    [Abstract] [Full Text] [Related]

  • 4. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
    Rada EM, Aranzazu N, Convit J.
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
    [No Abstract] [Full Text] [Related]

  • 5. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

  • 6. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
    Ilangumaran S, Shanker Narayan NP, Ramu G, Muthukkaruppan VR.
    Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
    [Abstract] [Full Text] [Related]

  • 7. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 8. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H, Schoel B, Chiplunkar S, Gangal S, Deo MG, Kaufmann SH.
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [Abstract] [Full Text] [Related]

  • 9. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
    Launois P, Blum L, Dieye A, Millan J, Sarthou JL, Michel JC, Bach MA.
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
    [Abstract] [Full Text] [Related]

  • 10. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH, Converse PJ, Gebre N, Wondimu A, Ehrenberg JP, Kiessling R.
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [Abstract] [Full Text] [Related]

  • 11. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mycobacterium leprae-induced interferon-gamma production by household contacts of leprosy patients: association with the development of active disease.
    Sampaio EP, Moreira AL, Kaplan G, Alvim MF, Duppre NC, Miranda CF, Sarno EN.
    J Infect Dis; 1991 Nov; 164(5):990-3. PubMed ID: 1940481
    [Abstract] [Full Text] [Related]

  • 15. Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household.
    Menzel S, Bjune G, Kronvall G.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):138-52. PubMed ID: 378871
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [Abstract] [Full Text] [Related]

  • 18. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ, Closs O, Belehu A.
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy.
    Converse PJ, Ottenhoff TH, Gebre N, Ehrenberg JP, Kiessling R.
    Scand J Immunol; 1988 May; 27(5):515-25. PubMed ID: 3131867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.